Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer

Gupta, 1873, Long non-coding RNAs and nuclear factor-kappaB crosstalk in cancer and other human diseases, Biochim Biophys Acta Rev Cancer, 2020, 188316

Chandra Gupta, 2017, Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets, Int J Cancer, 140, 1955, 10.1002/ijc.30546

Zhang, 2017, The long noncoding RNA Malat1: Its physiological and pathophysiological functions, RNA Biol, 14, 1705, 10.1080/15476286.2017.1358347

Ji, 2003, MALAT-1, a novel noncoding RNA, and thymosin β 4 predict metastasis and survival in early-stage non-small cell lung cancer, Oncogene, 22, 8031, 10.1038/sj.onc.1206928

Wilusz, 2008, 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA, Cell, 135, 919, 10.1016/j.cell.2008.10.012

Brown, 2014, Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix, Nat. Struct. Mol. Biol., 21, 633, 10.1038/nsmb.2844

Zong, 2016, Natural antisense RNA promotes 3′ end processing and maturation of MALAT1 lncRNA, Nucl. Acids Res., 44, 2898, 10.1093/nar/gkw047

Clark, 2012, Genome-wide analysis of long noncoding RNA stability, Genome Res., 22, 885, 10.1101/gr.131037.111

Tani, 2010, Stability of MALAT-1, a nuclear long non-coding RNA in mammalian cells, varies in various cancer cells, Drug Discov Ther, 4, 235

Fei, 2017, Quantitative analysis of multilayer organization of proteins and RNA in nuclear speckles at super resolution, J. Cell Sci., 130, 4180, 10.1242/jcs.206854

West, 2014, The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites, Molecular Cell, 55, 791, 10.1016/j.molcel.2014.07.012

Miyagawa, 2012, Identification of cis-and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles, RNA, 18, 738, 10.1261/rna.028639.111

Nguyen, 2020, The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis, Nucl. Acids Res., 48, 2621, 10.1093/nar/gkz1176

Wang, 2019, Imaging-based pooled CRISPR screening reveals regulators of lncRNA localization, Proc. Natl. Acad. Sci., 116, 10842, 10.1073/pnas.1903808116

Sun, 2018, Nuclear long noncoding RNAs: key regulators of gene expression, Trends Genetics, 34, 142, 10.1016/j.tig.2017.11.005

Li, 2018, MALAT1: a potential biomarker in cancer, Cancer Manage. Res., 10, 6757, 10.2147/CMAR.S169406

Fan, 2014, TGF-β–induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12, Clin. Cancer Res., 20, 1531, 10.1158/1078-0432.CCR-13-1455

Hirata, 2015, Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205, Cancer Res., 75, 1322, 10.1158/0008-5472.CAN-14-2931

Tripathi, 2010, The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, Molecular Cell, 39, 925, 10.1016/j.molcel.2010.08.011

Jadaliha, 2016, Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer, Oncotarget, 7, 40418, 10.18632/oncotarget.9622

Malakar, 2017, Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation, Cancer Res., 77, 1155, 10.1158/0008-5472.CAN-16-1508

Scherer, 2020, Quantitative Proteomics to Identify Nuclear RNA-Binding Proteins of Malat1, Int. J. Mol. Sci., 21, 1166, 10.3390/ijms21031166

Zheng, 2019, Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer, Bioscience Rep., 39, 10.1042/BSR20181284

Hu, 2020, Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network, Mol. Med. Rep., 22, 620, 10.3892/mmr.2020.11171

Arun, 2018, Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer, Oncotarget, 9, 18386, 10.18632/oncotarget.24841

Wang, 2017, Long non-coding RNA MALAT1 for promoting metastasis and proliferation by acting as a ceRNA of miR-144-3p in osteosarcoma cells, Oncotarget, 8, 59417, 10.18632/oncotarget.19727

Luan, 2016, Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22, Oncotarget, 7, 63901, 10.18632/oncotarget.11564

Gu, 2017, LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression, Oncotarget, 8, 101984, 10.18632/oncotarget.21957

Wang, 2016, The lnc RNA MALAT 1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer, J. Cellular Mol. Med., 20, 2299, 10.1111/jcmm.12920

Tao, 2018, miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma, FASEB J., 32, 6330, 10.1096/fj.201800495RR

Eißmann, 2012, Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development, RNA Biol., 9, 1076, 10.4161/rna.21089

Tiansheng, 2020, lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Proliferation and Invasion of Non-Small Cell Lung Cancer Cells via Down-Regulating miR-202 Expression, Cell J. (Yakhteh), 22

Mishra, 2019, Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases, Cell Mol Life Sci, 76, 1947, 10.1007/s00018-019-03053-0

Sanchez-Vega, 2018, Oncogenic signaling pathways in the cancer genome atlas, Cell, 173, 321, 10.1016/j.cell.2018.03.035

Liu, 2018, Knockdown of long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) inhibits proliferation, migration, and invasion and promotes apoptosis by targeting miR-124 in retinoblastoma, Oncol. Res. Featuring Preclin. Clin. Cancer Ther., 26, 581

Peng, 2020, Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis, Cancer Cell Int., 20, 1, 10.1186/s12935-020-01231-w

Zhou, 2018, Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling, J. Cellular Physiol., 233, 5805, 10.1002/jcp.26357

Zhang, 2017, MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1, Biomed. Pharmacother., 93, 1065, 10.1016/j.biopha.2017.07.005

Chen, 2018, LncRNA MALAT1 promotes cancer metastasis in osteosarcoma via activation of the PI3K-Akt signaling pathway, Cellular Physiol. Biochem., 51, 1313, 10.1159/000495550

Dong, 2015, MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway, Tumor Biol., 36, 1477, 10.1007/s13277-014-2631-4

Wu, 2019, JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway, J. Exp. Clin. Cancer Res., 38, 435, 10.1186/s13046-019-1439-x

Xu, 2020, Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway, J. Exp. Clin. Cancer Res., 39, 1, 10.1186/s13046-020-01562-6

Li, 2017, Long non-coding RNA MALAT1 promotes proliferation, angiogenesis, and immunosuppressive properties of mesenchymal stem cells by inducing VEGF and IDO, J. Cellular Biochem., 118, 2780, 10.1002/jcb.25927

Sun, 2016, Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial–mesenchymal transition, Mol. BioSystems, 12, 952, 10.1039/C5MB00685F

Sun, 2019, YAP1-induced MALAT1 promotes epithelial–mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer, Oncogene, 38, 2627, 10.1038/s41388-018-0628-y

Yu, 2019, Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer, Oncogene, 38, 1225, 10.1038/s41388-018-0463-1

Dai, 2019, Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells, Pathol. Res. Practice, 215, 712, 10.1016/j.prp.2019.01.011

Zhu, 2019, lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway, Oncol. Lett., 17, 5335

Fouad, 2017, Revisiting the hallmarks of cancer, Am. J. Cancer Res., 7, 1016

Si, 2019, Long non-coding RNA Malat1 activated autophagy, hence promoting cell proliferation and inhibiting apoptosis by sponging miR-101 in colorectal cancer, Cellular Mol. Biol. Lett, 24, 50, 10.1186/s11658-019-0175-8

Sun, 2019, LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p, OncoTargets Ther, 12, 6297, 10.2147/OTT.S214689

Hu, 2018, Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma, Leukemia, 32, 2250, 10.1038/s41375-018-0104-2

Hao, 2020, IL-6/STAT3 mediates the HPV18 E6/E7 stimulated upregulation of MALAT1 gene in cervical cancer HeLa cells, Virus Res, 197907

Zheng, 2019, IL-8 Secreted from M2 macrophages promoted prostate tumorigenesis via STAT3/MALAT1 pathway, Int J Mol Sci, 20, 98, 10.3390/ijms20010098

Wang, 2018, TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions, Cancer Lett, 436, 52, 10.1016/j.canlet.2018.08.009

Li, 2019, LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway, Life Sci, 239, 116946, 10.1016/j.lfs.2019.116946

Guo, 2015, Expression of MALAT1 in the peripheral whole blood of patients with lung cancer, Biomedical Rep, 3, 309, 10.3892/br.2015.422

Kim, 2018, Long noncoding RNA MALAT1 suppresses breast cancer metastasis, Nat Genetics, 50, 1705, 10.1038/s41588-018-0252-3

Cao, 2016, Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by suppressing miR-155 expression and activating FBXW7 function, Am J Cancer Res, 6, 2561

Li, 2016, Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma, Cancer Lett, 383, 28, 10.1016/j.canlet.2016.09.019

Kwok, 2018, A non-canonical tumor suppressive role for the long non-coding RNA MALAT1 in colon and breast cancers, Int J Cancer, 143, 668, 10.1002/ijc.31386

Latorre, 2016, The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer, Cancer Res, 76, 2626, 10.1158/0008-5472.CAN-15-2018

Ni, 2020, Meta-analysis of the association between MALAT1 rs619586 A> G polymorphism and cancer risk, J Int Med Res, 48, 10.1177/0300060520941969

Wu, 2019, MALAT1 rs664589 Polymorphism Inhibits Binding to miR-194-5p, Contributing to Colorectal Cancer Risk, Growth, and Metastasis, Cancer Res, 79, 5432, 10.1158/0008-5472.CAN-19-0773

Yang, 2020, MicroRNA Binding Site Polymorphisms of the Long-Chain Noncoding RNA MALAT1 are Associated with Risk and Prognosis of Colorectal Cancer in Chinese Han Population, Genetic Testing and Molecular Biomarkers, 24, 239, 10.1089/gtmb.2020.0013

Chen, 2020, Association of polymorphisms in MALAT1 with the risk of endometrial cancer in Southern Chinese women, J Clin Lab Analysis, 34

Wen, 2019, Effect of MALAT1 Polymorphisms on Papillary Thyroid Cancer in a Chinese Population, J Cancer, 10, 5714, 10.7150/jca.28887

Orlandi, 2019, Lack of association of metastasis-associated lung adenocarcinoma transcript 1 variants with melanoma skin cancer risk, Melanoma Res, 29, 660, 10.1097/CMR.0000000000000605

Zhao, 2020, Long Non-Coding RNA MALAT1 as a Detection and Diagnostic Molecular Marker in Various Human Cancers: A Pooled Analysis Based on 3255 Subjects, OncoTargets Ther, 13, 5807, 10.2147/OTT.S250796

Chen, 2017, Diagnostic efficacy of long non-coding RNA MALAT-1 in human cancers: a meta-analysis study, Oncotarget, 8, 102291, 10.18632/oncotarget.21013

Pan, 2020, Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis, Thoracic Cancer, 11, 329, 10.1111/1759-7714.13265

Jiang, 2020, Long Noncoding RNA Serve as a Potential Predictive Biomarker for Breast Cancer: A Meta-Analysis, BioMed Res Int, 2020

Sun, 2020, The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis, Cellular and Molecular Biology (Noisy-le-Grand, France), 66, 72, 10.14715/cmb/2020.66.3.11

Tornesello, 2020, The Role of microRNAs, Long Non-coding RNAs, and Circular RNAs in Cervical Cancer, Front. Oncol, 10, 150, 10.3389/fonc.2020.00150

Duan, 2016, Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer, Oncotarget, 7, 78850, 10.18632/oncotarget.12880

Yu, 2020, A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis, J Cancer, 11, 781, 10.7150/jca.37006

Li, 2018, Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis, Cancer Cell Int, 18, 109, 10.1186/s12935-018-0606-z

Ou, 2019, MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer, J Cancer Res Ther, 15, 1597, 10.4103/jcrt.JCRT_282_19

Wang, 2018, High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival, Breast Cancer Res Treatment, 171, 261, 10.1007/s10549-018-4839-2

Lv, 2020, Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy, Thoracic Cancer, 11, 29, 10.1111/1759-7714.13216

Qiu, 2018, Exosomal metastasis-associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer, Int J Biol Sci, 14, 1960, 10.7150/ijbs.28048

Gao, 2018, Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis, OncoTargets Ther, 11, 4877, 10.2147/OTT.S169823

Huang, 2016, Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients, Biomed Pharmacother, 83, 8, 10.1016/j.biopha.2016.05.044

Yuan, 2019, Genetic variants of lncRNA MALAT1 exert diverse impacts on the risk and clinicopathologic characteristics of patients with hepatocellular carcinoma, J Clin Med, 8, 1406, 10.3390/jcm8091406

Liu, 2019, Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis, Int J Surgery, 72, 206, 10.1016/j.ijsu.2019.11.004

Argadal, 2020, Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomas, Bosnian J Basic Med Sci, 20, 63

Jiao, 2018, LncRNA MALAT1 promotes tumor growth and metastasis by targeting miR-124/foxq1 in bladder transitional cell carcinoma (BTCC), Am J Cancer Res, 8, 748

Lin, 2018, Expression of metastasis-associated lung adenocarcinoma transcript 1 long non-coding RNA in vitro and in patients with non-small cell lung cancer, Oncol Lett, 15, 9443

Gutschner, 2013, The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells, Cancer Res, 73, 1180, 10.1158/0008-5472.CAN-12-2850

Gong, 2018, Antisense oligonucleotide-conjugated nanostructure-targeting lncRNA MALAT1 inhibits cancer metastasis, ACS Appl Mater Interfaces, 11, 37, 10.1021/acsami.8b18288

Amodio, 2018, Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity, Leukemia, 32, 1948, 10.1038/s41375-018-0067-3

Arun, 2020, MALAT1 Long Non-Coding RNA: Functional Implications, Non-Coding RNA, 6, 22, 10.3390/ncrna6020022

Wu, 2014, MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway, Cancer Biol Ther, 15, 806, 10.4161/cbt.28584

Ying, 2012, Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition, Mol Biosyst, 8, 2289, 10.1039/c2mb25070e

Chang, 2020, Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma, Cells, 9, 10.3390/cells9041020

Wang, 2014, MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF, Biomed Pharmacother, 68, 557, 10.1016/j.biopha.2014.04.007

Guo, 2010, Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion, Acta Biochim Biophys Sin (Shanghai), 42, 224, 10.1093/abbs/gmq008

Chang, 2018, MALAT1 silencing suppresses prostate cancer progression by upregulating miR-1 and downregulating KRAS, Onco Targets Ther, 11, 3461, 10.2147/OTT.S164131

Xiong, 2018, LncRNA MALAT1/miR-129 axis promotes glioma tumorigenesis by targeting SOX2, J Cell Mol Med, 22, 3929, 10.1111/jcmm.13667

Lin, 2018, MALAT1 affects ovarian cancer cell behavior and patient survival, Oncol Rep, 39, 2644

Lu, 2020, Quercetin Inhibits Epithelial-to-Mesenchymal Transition (EMT) Process and Promotes Apoptosis in Prostate Cancer via Downregulating lncRNA MALAT1, Cancer Manage Res, 12, 1741, 10.2147/CMAR.S241093

Ji, 2013, Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway, PloS One, 8, 10.1371/journal.pone.0078700

Tang, 2019, Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer, Cellular Signalling, 57, 21, 10.1016/j.cellsig.2019.01.013

Zhao, 2020, lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR-375 sponging, Molecular Med Rep, 22, 1449, 10.3892/mmr.2020.11196

Jin, 2019, m 6 A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis, J Hematol Oncol, 12, 135, 10.1186/s13045-019-0830-6

Chen, 2017, MALAT1-miR-101-SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway, Oncotarget, 8, 94317, 10.18632/oncotarget.21693

Bai, 2018, Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway, Exp. Cell Res, 366, 161, 10.1016/j.yexcr.2018.03.014

Fan, 2020, Long Noncoding RNA MALAT1 Contributes to Sorafenib Resistance by Targeting miR-140-5p/Aurora-A Signaling in Hepatocellular Carcinoma, Molecular Cancer Ther, 19, 1197, 10.1158/1535-7163.MCT-19-0203

Li, 2017, MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2, Molecular Cancer Therap, 16, 739, 10.1158/1535-7163.MCT-16-0591

Kim, 2018, Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide, Nucleic Acids Res, 46, 1424, 10.1093/nar/gkx1221

Wang, 2017, Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9® to suppress enzalutamide-resistant prostate cancer progression, Eur Urol, 72, 835, 10.1016/j.eururo.2017.04.005

Liu, 2019, LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer, Acta Biochimica et Biophysica Sinica, 51, 1148, 10.1093/abbs/gmz112

YiRen, 2017, Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer, Molecular Cancer, 16, 174, 10.1186/s12943-017-0743-3

Fellenberg, 2003, Identification of drug-regulated genes in osteosarcoma cells, Int J Cancer, 105, 636, 10.1002/ijc.11135

Fellenberg, 2007, Prognostic significance of drug-regulated genes in high-grade osteosarcoma, Mod Pathol, 20, 1085, 10.1038/modpathol.3800937

Guo, 2020, Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging, Exp Mol Pathol, 104448

Li, 2017, Long noncoding RNA MALAT 1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression, J Oral Pathol Med, 46, 583, 10.1111/jop.12538

Huang, 2019, Long noncoding RNA MALAT1 mediates cardiac fibrosis in experimental postinfarct myocardium mice model, J Cell Physiol, 234, 2997, 10.1002/jcp.27117

Sun, 2019, Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis, Biomed Pharmacother, 111, 1036, 10.1016/j.biopha.2018.12.122

Puthanveetil, 2015, Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells, J Cell Mol Med, 19, 1418, 10.1111/jcmm.12576

Biswas, 2018, MALAT1: An Epigenetic Regulator of Inflammation in Diabetic Retinopathy, Sci Rep, 8, 6526, 10.1038/s41598-018-24907-w

Radhakrishnan, 2020, Long noncoding RNA MALAT1 and Regulation of the Antioxidant Defense System in Diabetic Retinopathy, Diabetes, 2020, 4729019

Zhou, 2020, Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance, J Diabetes Res, 2020, 4729019, 10.1155/2020/4729019

Bernard, 2010, A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression, EMBO J, 29, 3082, 10.1038/emboj.2010.199

Cardamone, 2019, Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis, Hum Mol Genet, 28, 1414, 10.1093/hmg/ddy438

Gong, 2019, Long noncoding RNA MALAT1 promotes cardiomyocyte apoptosis after myocardial infarction via targeting miR-144-3p, Biosci Rep, 39, 10.1042/BSR20191103

Guo, 2017, Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke, Cell Physiol Biochem, 43, 182, 10.1159/000480337

Ponting, 2009, Evolution and functions of long noncoding RNAs, Cell, 136, 629, 10.1016/j.cell.2009.02.006

Song, 2020, Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer, Eur. Rev. Med. Pharmacol. Sci, 24, 1853

Liu, 2019, MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression, Biomed Pharmacother, 114, 108847, 10.1016/j.biopha.2019.108847

Chen, 2019, TFAP2C-activated MALAT1 modulates the chemoresistance of docetaxel-resistant lung adenocarcinoma cells, Molecular Therapy-Nucleic Acids, 14, 567, 10.1016/j.omtn.2019.01.005

Stone, 2019, Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells, J Biol Chem, 294, 11213, 10.1074/jbc.RA118.006889

Xia, 2018, Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells, Eur J Pharmacol, 830, 59, 10.1016/j.ejphar.2018.04.027

Gu, 2019, Reciprocal Feedback Loop of the MALAT1-MicroRNA-194-YAP1 Pathway Regulates Progression of Acute Pancreatitis, Med Sci Monitor, 25, 6894, 10.12659/MSM.915598

Shao, 2020, Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer, Oncol Lett, 19, 805

Yang, 2019, Resveratrol suppresses the invasion and migration of human gastric cancer cells via inhibition of MALAT1-mediated epithelial-to-mesenchymal transition, Exp Ther Med, 17, 1569

Hao, 2020, MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis, Biomed Pharmacother, 123, 109666, 10.1016/j.biopha.2019.109666

Ye, 2019, Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network, Exp Ther Med, 17, 3035

Herrero, 2020, FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma, J Cellular Mol Med, 24, 4171, 10.1111/jcmm.15078

Liu, 2020, Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis, J Cancer Res Clin Oncol, 146, 367, 10.1007/s00432-020-03127-8

Sun, 2019, LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of hippo-YAP signaling pathway, Cell Cycle, 18, 2509, 10.1080/15384101.2019.1652034

Ji, 2019, MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis, Cell Death Disease, 10, 1, 10.1038/s41419-019-1598-x

Zhuang, 2019, MALAT1 sponges miR-106b-5p to promote the invasion and metastasis of colorectal cancer via SLAIN2 enhanced microtubules mobility, EBioMedicine, 41, 286, 10.1016/j.ebiom.2018.12.049

Zhao, 2019, Long Noncoding RNA MALAT1 regulates hepatocellular carcinoma growth under hypoxia via sponging MicroRNA-200a, Yonsei Med J, 60, 727, 10.3349/ymj.2019.60.8.727

He, 2019, Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling, J Cellular Biochem, 120, 2908, 10.1002/jcb.26823

Lin, 2019, Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells, J Exp Clin Cancer Res, 38, 1, 10.1186/s13046-019-1237-5

Yuan, 2019, LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression, Eur Rev Med Pharmacol Sci, 23, 198

Han, 2019, Suppression of the long non-coding RNA MALAT-1 impairs the growth and migration of human tongue squamous cell carcinoma SCC4 cells, Arch Med Sci, 15, 992, 10.5114/aoms.2018.73343

Du, 2018, TGF-β regulates the ERK/MAPK pathway independent of the SMAD pathway by repressing miRNA-124 to increase MALAT1 expression in nasopharyngeal carcinoma, Biomed Pharmacother, 99, 688, 10.1016/j.biopha.2018.01.120

Ma, 2020, LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384/GOLM1 axis in glioma, Eur Rev Med Pharmacol Sci, 24, 2601

Yang, 2020, Front Immunol, 10, 3161, 10.3389/fimmu.2019.03161

Voce, 2019, Temozolomide treatment induces lncRNA MALAT1 in an NF-κB and p53 codependent manner in glioblastoma, Cancer Res, 79, 2536, 10.1158/0008-5472.CAN-18-2170

Liao, 2019, Blocking lncRNA MALAT1/miR-199a/ZHX1 axis inhibits glioblastoma proliferation and progression, Mol Ther Nucl Acids, 18, 388, 10.1016/j.omtn.2019.09.005

Wu, 2020, The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm, Med Sci Monitor, 26, 10.12659/MSM.922012

Gordon, 2019, The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing, Mol. Carcinogenesis, 58, 196, 10.1002/mc.22919